MiR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 763-769

  He, Siyi ^a   Liu, Peng ^a   Jian, Zhao ^a   Li, Jingwei ^a   Zhu, Yun ^a   Feng, Zezhou ^a   Xiao, Yingbin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hypoxic adaptation; MiR 138; MLK3

Indexed keywords

CASPASE 3; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 138; MIXED LINEAGE KINASE 3; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONGENITAL HEART DISEASE; ENZYME ACTIVATION; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN TISSUE; HYPOXIA; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; HYPOXIC ADAPTATION; MIR-138; MLK3;

ADOLESCENT; ADULT; ANIMALS; ANOXIA; APOPTOSIS; CELL LINE; CELL SURVIVAL; CHILD; CYANOSIS; HEART DEFECTS, CONGENITAL; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE KINASE KINASES; MICRORNAS; MYOCYTES, CARDIAC; RATS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84888827430     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.151     Document Type: Article

References (26)

1. Rafiee P., Shi Y., Kong X., et al. Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. Circulation 2002, 106:239-245.
2. Kolar F., Ostadal B. Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol. Res. 2004, 53(Suppl. 1):S3-S13.
3. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
4. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
5. Morton S.U., Scherz P.J., Cordes K.R., et al. MicroRNA-138 modulates cardiac patterning during embryonic development. Proc. Natl. Acad. Sci. USA 2008, 105:17830-17835.
6. Wu T.S., Yang J.J., Yu F.Y., et al. Cardiotoxicity of mycotoxin citrinin and involvement of microRNA-138 in zebrafish embryos. Toxicol. Sci. 2013, http://dx.doi.org/10.1093/toxsci/kft206.
7. Li S., Ran Y., Zhang D., et al. MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1. Biochem. J. 2013, 452:281-291.
8. Ye D., Wang G., Liu Y., et al. MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling. Stem Cells 2012, 30:1645-1654.
9. Jian Z., Li J.B., Ma R.Y., et al. Increase of macrophage migration inhibitory factor (MIF) expression in cardiomyocytes during chronic hypoxia. Clin. Chim. Acta 2009, 405:132-138.
10. Brancho D., Ventura J.J., Jaeschke A., et al. Role of MLK3 in the regulation of mitogen-activated protein kinase signaling cascades. Mol. Cell. Biol. 2005, 25:3670-3681.
11. Christoforou E., Papassotiriou I., Skarmoutsou C., et al. Soluble transferrin receptors and tissue oxygenation in non anaemic cystic fibrosis patients. J. Cyst. Fibros. 2005, 4:151-156.
12. Rafiee P., Shi Y., Pritchard K.A., et al. Cellular redistribution of inducible Hsp70 protein in the human and rabbit heart in response to the stress of chronic hypoxia: role of protein kinases. J. Biol. Chem. 2003, 278:43636-43644.
13. Gallo K.A., Johnson G.L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 2002, 3:663-672.
14. Mishra R., Barthwal M.K., Sondarva G., et al. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3. J. Biol. Chem. 2007, 282:30393-30405.
15. Saporito M.S., Brown E.M., Miller M.S., et al. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J. Pharmacol. Exp. Ther. 1999, 288:421-427.
16. Sui Z., Fan S., Sniderhan L., et al. Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation. J. Immunol. 2006, 177:702-711.
17. Graham S.H., Chen J. Programmed cell death in cerebral ischemia. J. cereb. Blood Flow Metab. 2001, 21:99-109.
18. Tsujimoto Y., Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 2000, 466:6-10.
19. Korsmeyer S.J., Shutter J.R., Veis D.J., et al. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 1993, 4:327-332.
20. Kim K.Y., Kim B.C., Xu Z., et al. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells. J. Biol. Chem. 2004, 279:29478-29484.
21. Kumar A., Byun H.S., Bittman R., et al. The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cell. Signal. 2011, 23:1144-1152.
22. Mikhailov V., Mikhailova M., Pulkrabek D.J., et al. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J. Biol. Chem. 2001, 276:18361-18374.
23. Wolter K.G., Hsu Y.T., Smith C.L., et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 1997, 139:1281-1292.
24. Liu J., Lin A. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 2005, 15:36-42.
25. Morel S., Milano G., Ludunge K.M., et al. Brief reoxygenation episodes during chronic hypoxia enhance posthypoxic recovery of LV function: role of mitogen-activated protein kinase signaling pathways. Basic Res. Cardiol. 2006, 101:336-345.
26. Tarzami S.T., Calderon T.M., Deguzman A., et al. MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway. Biochem. Biophys. Res. Commun. 2005, 335:1008-1016.